Interventional therapy of coronary artery disease in China: Retrospective and perspective

Chinese Medical Journal

Volumn 121, Issue 22, 2008, Pages 2336-2341

  Shen, Wei Fe ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Coronary artery disease; Interventional therapy

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; FOSINOPRIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICORANDIL; PACLITAXEL; RAPAMYCIN; TIROFIBAN; VALSARTAN;

ACUTE CORONARY SYNDROME; AMBULANCE; ARTERY CALCIFICATION; ARTICLE; BLEEDING; CHINA; CLINICAL PATHWAY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; DRUG ELUTING STENT; ELDERLY CARE; HEALTH CARE DELIVERY; HEART INFARCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE REPERFUSION; HIGH RISK PATIENT; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; KIDNEY FAILURE; OUTCOME ASSESSMENT; PATIENT SAFETY; PATIENT TRANSPORT; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION; SURVIVAL RATE; THROMBOSIS;

EID: 62749156402     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200811020-00022     Document Type: Article

References (47)

1. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2008; 51: 210-247.
2. Nallamothu BK, Bradley EH, Krumholz HM. Time to treatment in primary percutaneous coronary intervention. N Engl J Med 2007; 357: 1631-1638.
3. Shavelle DM, Rasouli ML, Frederick P, Gibson CM, French WJ. Outcome in patients transferred for percutaneous coronary intervention (a national registry of myocardial infarction 2/3/4 analysis). Am J Cardiol 2005; 96: 1227-1232.
4. Parikh SV, Jacobi JA, Chu E, Addo TA, Warner JJ, Delaney KA, et al. Treatment delay in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a key process analysis of patient and program factors. Am Heart J 2008; 155: 290-297.
5. Herlitz J, Hjalter L, Karlson BW, Suserud BO, Karlsson T. Characteristics and outcome of patients with acute chest pain in relation to the use of ambulances in an urban and a rural area. Am J Emerg Med 2006; 24: 775-781.
6. Song L, Hu DY, Yan HB, Yang JG, Sun YH, Chao L, et al. Influence of ambulance use on early reperfusion therapies for acute myocardial infarction. Chin Med J 2008; 121: 771-775.
7. Amit G, Cafri C, Gilutz H, Ilia R, Zahger D. Benefit of direct ambulance to coronary care unit admission of acute myocardial infarction patients undergoing primary percutaneous intervention. Int J Cardiol 2007; 119: 355-358.
8. Boden WE, Eagle K, Granger CB. Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management opinions. J Am Coll Cardiol 2007; 50: 917-929.
9. Gao RL. Shortening the door-to-balloon time for transferring primary percutaneous coronary intervention: physician transfer may be a better way in China. Chin Med J 2008; 121: 483-484.
10. Zhang Q, Zhang RY, Qiu JP, Zhang JF, Wang XL, Jiang L, et al. Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction. Chin Med J 2008; 121: 485-491.
11. Zhang Q, Zhang RY, Jin HG, Qiu JP, Chen YH, Wang XL, et al. Impact of different clinical pathways on outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention (The RAPID-AMI Study). Int J Cardiol 2008; in press.
12. Carstensen S, Nelson GC, Hansen PS, Macken L, Irons S, Flynn M, et al. Field triage to primary angioplasty combined with emergency department bypass reduces treatment delays and is associated with improved outcome. Eur Heart J 2007; 28: 2313-2319.
13. Shen J, Zhang Q, Zhang RY, Zhang JS, Hu J, Yan ZK, et al. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Coron Artery Dis 2008; 19: 271-277.
14. Fu XH, Hao QQ, Jia XW, Fan WZ, Gu XH, Wu WL, et al. Effect of tirofiban plus clopidogrel and aspirin on primary percutaneous coronary intervention via transradial approach in patients with acute myocardial infarction. Chin Med J 2008; 121: 522-527.
15. Yang YJ, Zhao JL, You SJ, Wu YJ, Jing ZC, Gao RL, et al. Post-infarction treatment with simvastatin reduces myocardial no-reflow by opening of the KATP channel. Eur J Heart Fail 2007; 9: 30-36.
16. Zhao JL, Yang YJ, You SJ, Jing ZC, Wu YJ, Chen JL, et al. Pretreatment with fosinopril or valsartan reduces myocardial no-reflow after acute myocardial infarction and reperfusion. Coron Artery Dis 2006; 17: 463-469.
17. Zhao JL, Yang YJ, Chen JL, Kang LM, Wu Y, Gao RL. Nicorandil reduces myocardial no-reflow by protection of endothelial function via the activation of KATP channel. Clin Chim Acta 2006; 374: 100-105.
18. Zhao JL, Yang YJ, Cui CJ, You SJ, Wu YJ, Gao RL. Different effects of adenosine and calcium channel blockade on myocardial no-reflow after acute myocardial infarction and reperfusion. Cardiovasc Drugs Ther 2006; 20: 167-175.
19. Zhao JL, Yang YJ, Zhang YH, Pei WD, Sun YH, Chen JL, et al. Chronic pretreatment of ACEI reduces no-reflow in patients with acute myocardial infarction treated with primary angioplasty. Clin Cardiol 2007; 30: 130-134.
20. Yan HB, Wang J, Li N, Zhu XL, Gao H, Ai H, et al. Diver CE versus Guardwire Plus for thrombectomy in patients with inferior myocardial infarction: a trial of aspiration of thrombus during primary angioplasty for inferior myocardial infarction. Chin Med J 2007; 120: 557-561.
21. Yang ZK, Shen WF, Zhang RY, Kong Y, Zhang JS, Hu J, et al. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease. J Interv Cardiol 2007; 20: 10-16.
22. Bassand JP. Management of non ST segment elevation acute coronary syndromes: a shift in the paradigm. Chin Med J 2008; 121: 3-5.
23. Ma HY, Zhou YJ, Dick RJ, Shi DM, Liu YY, Cheng WJ, et al. Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent. Chin Med J 2008; 121: 887-891.
24. Yan ZX, Zhou YJ, Zhao YX, Liu YY, Shi DM, Guo YH, et al. Safety and feasibility of transradial approach for primary percutaneous coronary intervention in elderly patients with acute myocardial infarction. Chin Med J 2008; 121: 782-786.
25. Shen WF. Screening for coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. Chin Med J 2007; 120: 1859-1861.
26. Yang YJ, Xu B, Kang S, Pei WD, Chen JL, Qiao SB, et al. Comparison of in-hospital and long-term outcomes between a Cypher stent and a Taxus stent in Chinese diabetic patients with coronary artery disease. Chin Med J 2007; 120: 1868-1873.
27. Zhang Q, Shen J, Zhang RY, Qiu JP, Lu JD, Zhang Y, et al. Outcomes after primary coronary intervention with drug-eluting stent implantation in diabetic patients with acute ST elevation myocardial infarction. Chin Med J 2007; 120: 1862-1867.
28. Zhang Q, Ma CS, Nie SP, Du X, Lv Q, Kang JP, et al. Prevalence and impact of renal insufficiency on clinical outcomes of patients undergoing coronary revascularization. Circ J 2007; 71: 1299-1304.
29. Zhang RY, Ni JW, Zhang JS, Hu J, Yang ZK, Zhang Q, et al. Long term clinical outcomes in patients with moderate renal insufficiency undergoing stent based percutaneous coronary intervention. Chin Med J 2006; 119: 1176-1181.
30. Zhang RY, Zhu ZB, Zhang Q, Yang ZK, Hu J, Lü AK, et al. Impact of moderate or severe renal insufficiency on long-term outcomes in patients undergoing drug-eluting stent based coronary intervention. Int J Cardiol 2008; Jul 22. Epub ahead of print.
31. Zhu ZB, Zhang RY, Zhang Q, Zhang JS, Hu J, Yang ZK, et al. Moderate-severe renal insufficiency is a risk factor for sirolimus-eluting stent thrombosis. The RIFT Study. Cardiology 2008; 112: 191-199.
32. Gao RL, Xu B, Chen JL, yang YJ, Qiao SB, Li JJ, et al. Immediate and long-term outcomes of drug-eluting stent implantation for unprotect left main coronary artery disease: comparison with bare-metal stent implantation. Am Heart J 2008; 155: 553-561.
33. Han YL, Wang SL, Jin QM, Liu HW, Ma YY, Wang ZL, et al. Efficacy of stenting for unprotected left main coronary artery disease in 297 patients. Chin Med J 2006; 119: 544-550.
34. Chen JL, Gao RL, Yang YJ, Qiao SB, Qin XW, Yao M, et al. Short and long-term outcomes of two drug eluting stents in bifurcation lesions. Chin Med J 2007; 120: 183-186.
35. Chen S, Zhang J, Ye F, Zhu Z, Lin S, Shan S, et al. DK crush (double-kissing and double-crush) technique for treatment of true coronary bifurcation lesions: illustration and comparison with classic crush. J Invasive Cardiol 2007; 19: 189-193.
36. Chen SL, Zhang JJ, Ye F, Chen YD, Patel T, Kawajiri K, et al. Study comparing the double kissing (DK) crush with classical crush for the treatment of coronary bifurcation lesions: the DKCRUSK-1 Bifurcation Study with drug-eluting stents. Eur J Clin Invest 2008; 38: 361-371.
37. Chen SL, Zhang JJ, Ye F, Chen YD, Zhu ZS, Lin S, et al. Crush stenting in treating coronary bifurcation lesions: paclitaxel eluting stents versus sirolimus eluting stents. Chin Med J 2008; 121: 528-533.
38. Han YL, Wang SL, Jing QM, Li Y, Zhang J, Ma YY, et al. Percutaneous coronary intervention for chronic total occlusion in 1263 patients: a single-center report. Chin Med J 2006; 119: 1165-1170.
39. Han YL, Li Y, Wang SL, Jing QM, Ma YY, Wang G, et al. Multi-wire plaque crushing as a novel technique in treating chronic total occlusion. Chin Med J 2008; 121: 518-521.
40. Li JJ, Xu B, Yang YJ, Chen JL, Qiao SB, Ma WH, et al. Effects of sirolimus-eluting stent on calcified coronary lesions. Chin Med J 2008; 121: 6-11.
41. Gao RL, Xu B, Lu SZ, Chen JL, Han YL, Chen JZ, et al. Safety and efficacy of the CYPHER Select Sirolimus-eluting stent in the "Real World" - clinical and angiographic results from the China CYPHER select registry. Int J Cardiol 2008; 125: 339-346.
42. Zhang Q, Xu B, Yang YJ, Zhang RY, Li JJ, Qiao SB, et al. Sirolimus-eluting cobalt alloyed stents in treating patients with coronary artery disease: six-month angiographic and one-year clinical follow-up result. A prospective, historically controlled, multi-center clinical study. Chin Med J 2007; 120: 533-538.
43. Xu B, Zhang Q, Yang YJ, Qiao SB, Zhang RY, Zhang JS, et al. Sirolimus-eluting cobalt-chromium stents: two-year clinical results from first-in-man study on the Firebird 2 stent. Chin Med J 2008; 121: 492-497.
44. Huo Y, for Multicenter Registration Group. China multi-center Study of Acute and sub-acute Thrombosis Incidence Following Implantation of drug-eluting Stent. Chin Intervent Cardiol (Chin) 2005; 13: 131-134.
45. Chen JL, Yang YJ, Huang JH, Qin XW, Qiao SB, Yao M, et al. The incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease in the real world: a single center registry study. Chin J Cardiol (Chin) 2007; 35: 1133-1135.
46. Qian JY, Zhang F, Fan B, Ge L, Wang QB, Ge JB. A more than 2-year follow-up of incomplete apposition after drug-eluting stent implantation. Chin Med J 2008; 121: 498-502.
47. Han YL, Su QF, Li Y, Wang SL, Jing QM, Ma YY, et al. Short-term outcomes of triple antiplatelet therapy after percutaneous coronary intervention. Natl Med J China (Chin) 2006; 86: 1093-1096.